Skip to content

Clinical trials

COVID-19 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Country / region: China Clear all

419 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20181
20192
2020115
202189
2022106
202389
202411
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status202
Completed172
Withdrawn13
Recruiting12
Terminated10
Suspended4
Active, not recruiting3
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jiangsu Province Centers for Disease Control and Prevention15
Sinovac Research and Development Co., Ltd.15
China National Biotec Group Company Limited12
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.10
Sinovac Life Sciences Co., Ltd.10
Tongji Hospital8
Livzon Pharmaceutical Group Inc.7
RenJi Hospital7
Southeast University, China7
CanSino Biologics Inc.6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-19419
Coronavirus Infections14
Infections9
Pneumonia9
Influenza, Human6
Post-Acute COVID-19 Syndrome6
Postoperative Complications6
HIV Infections5
Respiratory Distress Syndrome5
Anxiety Disorders4

Trials

Showing 51 to 75 of 419. Each trial links to its page on Pharma Observatory.

319 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.